Splenda (sucralose) is not directly toxic to your liver at normal consumption levels, but emerging research raises legitimate concerns about indirect effects, particularly when sucralose is consumed alongside carbohydrates or over long periods. Most sucralose passes through your body undigested and unabsorbed, which means very little of it ever reaches your liver in the first place. The picture gets more complicated, though, when you look at what sucralose does to your gut bacteria, your insulin response, and a breakdown product it produces called sucralose-6-acetate.
Most Sucralose Never Reaches Your Liver
Your body doesn’t recognize sucralose as a carbohydrate. Unlike regular sugar, which gets absorbed in the small intestine and processed by the liver, sucralose passes through your digestive tract largely unchanged and is eliminated in your stool. Only insignificant amounts are absorbed from the GI tract. This is actually the core reason sucralose has zero calories: your body can’t break it down or use it for energy.
This minimal absorption is also why the FDA approved sucralose as safe in 1999 after reviewing more than 110 toxicity studies. The current acceptable daily intake is 5 milligrams per kilogram of body weight per day. For a 150-pound person, that works out to about 340 milligrams daily, or roughly 23 packets of Splenda.
The Sucralose-6-Acetate Problem
One of the more concerning findings in recent years involves sucralose-6-acetate, a compound that forms when sucralose breaks down. It’s also present as a trace impurity in commercial sucralose products. A 2023 study published in the Journal of Toxicology and Environmental Health found that sucralose-6-acetate is genotoxic, meaning it can damage DNA. Specifically, it acts as a clastogen, producing breaks in DNA strands.
In lab tests on human cells, sucralose-6-acetate significantly increased the activity of genes linked to inflammation, oxidative stress, and cancer. The compound also inhibited two liver enzymes in the cytochrome P450 family (CYP1A2 and CYP2C19), which play a key role in how your liver metabolizes drugs and clears toxins. If these enzymes are suppressed, your liver may process certain medications more slowly, potentially allowing harmful substances to linger longer in your body. This is a test-tube finding, not yet confirmed in human studies at typical dietary exposures, but it has prompted serious discussion among toxicologists.
What Happens When You Combine Splenda With Food
One of the most striking findings comes from a study published in Cell Metabolism, which found that drinking sucralose alongside carbohydrates (the way most people actually consume it, in sweetened coffee with breakfast or a diet soda with a meal) impairs glucose metabolism in ways that sucralose alone does not. Participants who consumed sucralose paired with a carbohydrate showed significantly elevated insulin levels compared to those who had sugar alone or sucralose alone. The study also found that this combination increased a specific marker of hepatic insulin resistance, meaning the liver became less responsive to insulin’s signal to stop producing glucose.
This matters because hepatic insulin resistance is an early step on the path toward fatty liver disease and type 2 diabetes. When your liver ignores insulin, it keeps pumping glucose into your bloodstream even when levels are already high, and it begins storing more fat. The study was notable enough that a parallel trial in adolescents was actually terminated early after two participants in the sucralose-plus-carbohydrate group developed highly elevated insulin and insulin resistance scores.
Sucralose triggers these effects partly by activating sweet taste receptors in your gut and pancreas. These receptors influence how your intestines absorb glucose and how your body releases hormones that regulate blood sugar. When your brain tastes something sweet but the expected calories don’t arrive, and then actual sugar shows up alongside it, the signaling gets confused.
Gut Bacteria Changes That Affect the Liver
Your gut and liver are closely connected through what researchers call the gut-liver axis. Blood from your intestines flows directly to your liver through the portal vein, carrying nutrients, bacteria, and inflammatory signals. Changes in your gut environment can therefore have outsized effects on liver health.
Chronic sucralose consumption reshapes the gut microbiome in unfavorable ways. It reduces populations of beneficial bacteria that produce butyrate, a short-chain fatty acid that keeps your intestinal lining healthy and tamps down inflammation. At the same time, it promotes the growth of pro-inflammatory bacterial species. In mouse studies, six weeks of sucralose exposure at levels comparable to the acceptable daily intake led to significant gut inflammation, with increased infiltration of immune cells into the colon and elevated production of inflammatory signaling molecules like TNF-alpha, IL-1beta, and IL-6.
Sucralose also appears to weaken the physical barrier of the intestinal wall. Expression of tight junction proteins, the molecular “glue” that holds gut lining cells together, drops significantly with sucralose exposure. When this barrier weakens, bacterial products can leak into the portal blood and reach the liver, triggering an inflammatory response there. This “leaky gut” mechanism is one of the recognized drivers of non-alcoholic fatty liver disease, and it may explain why some researchers have flagged sucralose as a potential contributor to chronic liver disease even though the sweetener itself is barely absorbed.
Animal Studies Show Elevated Liver Enzymes
Direct evidence of liver stress from sucralose comes primarily from animal research. In one study on rats given sucralose daily, levels of ALT (a liver enzyme that rises when liver cells are damaged) increased from 40 to 50 units per liter, while AST (another liver damage marker) climbed from 120 to 150 units per liter. These aren’t massive spikes, but they indicate that liver cells were under stress. The doses used in that study (3 grams per kilogram of body weight) were far higher than any human would consume, which makes it difficult to translate directly to people, but the direction of the effect is consistent with the inflammation and metabolic disruption seen in other research.
No large-scale human trials have yet measured liver enzymes in people consuming typical amounts of Splenda over months or years. That gap in the evidence is part of what makes this question hard to answer definitively.
Putting the Risk in Perspective
If you use one or two packets of Splenda a day in your coffee, the amount of sucralose reaching your liver is tiny, and there’s no strong evidence that this level of exposure causes liver damage. The FDA’s safety assessment still stands, and sucralose remains one of the most widely approved artificial sweeteners globally.
The concerns are more relevant for people who consume sucralose frequently throughout the day, in diet sodas, protein shakes, flavored waters, sugar-free snacks, and sweetened coffee combined. At higher and more consistent intake levels, the cumulative effects on gut bacteria, intestinal barrier integrity, and insulin signaling become harder to dismiss. The pairing of sucralose with carbohydrate-containing meals, which describes how most people actually use it, appears to be more metabolically disruptive than sucralose consumed in isolation.
If you already have risk factors for fatty liver disease (carrying extra weight around the midsection, insulin resistance, high triglycerides), the indirect metabolic effects of heavy sucralose use could compound those risks. For people with healthy livers and moderate intake, the current evidence suggests the risk is low but not zero, and the science is still catching up to how widely this sweetener is consumed.